We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Antibodies from 1918 Flu Survivors Protect Against the Virus

By LabMedica International staff writers
Posted on 28 Aug 2008
A team of immunologists and virologists has successfully recovered immune system B cells from survivors of the 1918 influenza pandemic and used them to prepare monoclonal antibodies that provided protection against infection with the virus.

Investigators at Vanderbilt University (Nashville, TN, USA) collected blood samples from 32 survivors of the 1918 pandemic now aged from 91-101 years. Sera from all the survivors demonstrated positive immune responses to the 1918 virus, suggesting that they still possessed antibodies to the virus.

A subset of seven donor samples tested had circulating B cells that secreted antibodies that bound the 1918 haemagglutinin (HA) protein antigen. The investigators isolated B cells from these subjects and generated five monoclonal antibodies that showed potent neutralizing activity against the 1918 virus from three separate donors. These antibodies also cross-reacted with the genetically similar HA of a 1930 swine H1N1 influenza strain, but did not cross-react with HAs of more contemporary human influenza viruses. The antibodies bound to the 1918 HA protein with high affinity, had exceptional virus-neutralizing potency, and protected mice from lethal infection.

"The B cells have been waiting for at least 60 years – if not 90 years – for that flu to come around again,” said senior author Dr. James Crowe, professor of pediatrics at Vanderbilt University. "That is amazing…because it is the longest memory anyone's ever demonstrated. The lessons we are learning about the 1918 flu tell us a lot about what may happen during a future pandemic.”

The investigators concluded their paper in the August 17, 2008, online edition of the journal Nature with the observation: "These studies demonstrate that survivors of the 1918 influenza pandemic possess highly functional, virus-neutralizing antibodies to this uniquely virulent virus, and that humans can sustain circulating B memory cells to viruses for many decades after exposure—well into the tenth decade of life.”

Related Links:
Vanderbilt University


New
Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Automated Blood Typing System
IH-500 NEXT
New
Free Human Prostate-Specific Antigen CLIA
LIAISON fPSA
New
Silver Member
Benchtop Image Acquisition Device
Microwell Imager

Latest BioResearch News

Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns

Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma

New Method Simplifies Preparation of Tumor Genomic DNA Libraries